SABS SAB Biotherapeutics
- 2.9200
- -0.0300-1.02%
- 2.9200
- 0.00000.00%
SAB Biotherapeutics News
8-K: Current report
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
8-K: Current report
8-K: Current report
DEF 14A: Definitive information statements
8-K: Current report
NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | 8-K: Current report
SAB Biotherapeutics | DEF 14A: Definitive information statements
SAB Biotherapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Analysis
Price Target
No Data
No Data